Bioera SpA
MIL:BIE
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.0125
0.124
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BIE stock under the Base Case scenario is 0.148 EUR. Compared to the current market price of 0.066 EUR, Bioera SpA is Undervalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Bioera SpA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BIE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Bioera SpA
Balance Sheet Decomposition
Bioera SpA
Current Assets | 1.5m |
Cash & Short-Term Investments | 279k |
Receivables | 830k |
Other Current Assets | 437k |
Non-Current Assets | 2.3m |
Long-Term Investments | 30k |
PP&E | 1.5m |
Intangibles | 390k |
Other Non-Current Assets | 401k |
Current Liabilities | 19.1m |
Accounts Payable | 5.7m |
Accrued Liabilities | 662k |
Short-Term Debt | 5m |
Other Current Liabilities | 7.7m |
Non-Current Liabilities | -99k |
Long-Term Debt | 5.5m |
Other Non-Current Liabilities | -5.6m |
Earnings Waterfall
Bioera SpA
Revenue
|
1.6m
EUR
|
Cost of Revenue
|
-668k
EUR
|
Gross Profit
|
932k
EUR
|
Operating Expenses
|
-4.3m
EUR
|
Operating Income
|
-3.4m
EUR
|
Other Expenses
|
-214k
EUR
|
Net Income
|
-3.6m
EUR
|
Free Cash Flow Analysis
Bioera SpA
EUR | |
Free Cash Flow | EUR |
BIE Profitability Score
Profitability Due Diligence
Bioera SpA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Bioera SpA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
BIE Solvency Score
Solvency Due Diligence
Bioera SpA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Score
Bioera SpA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIE Price Targets Summary
Bioera SpA
Dividends
Current shareholder yield for BIE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Bioera SpA is a holding company, which engages in the production and sale of organic products, natural cosmetics, and traditional food products. The company is headquartered in Milan, Milano and currently employs 3 full-time employees. The company went IPO on 2005-07-27. The company’s activities are divided into two sectors. The Biological and Natural products sector, through its subsidiaries and affiliated entities, is active in the distribution of natural and organic products; production of organic food from vegetables; manufacture of oil from organic agriculture, and distribution of traditional food products, as well as in the sector of natural origin cosmetics. The Holding sector provides activities of the Company as a parent of the group. The firm controls entities, such as Organic Oils Italia Srl, La Fonte della Vita Srl, KI Group SpA and Organic Food Retail Srl.
Officers
The intrinsic value of one BIE stock under the Base Case scenario is 0.148 EUR.
Compared to the current market price of 0.066 EUR, Bioera SpA is Undervalued by 55%.